Authors:
MURPHY EL
GLYNN S
WATANABE K
FRIDEY J
SMITH J
SACHER R
WRIGHT D
SCHREIBER G
LUBAN N
Citation: El. Murphy et al., LABORATORY TEST DIFFERENCES ASSOCIATED WITH HTLV-I AND HTLV-II INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 17(4), 1998, pp. 332-338
Authors:
MURPHY EL
MAHIEUX R
DETHE G
TEKAIA F
AMETI D
HORTON J
GESSAIN A
Citation: El. Murphy et al., MOLECULAR EPIDEMIOLOGY OF HTLV-II AMONG UNITED-STATES BLOOD-DONORS AND INTRAVENOUS-DRUG-USERS - AN AGE-COHORT EFFECT FOR HTLV-II RFLP TYPE AO, Virology, 242(2), 1998, pp. 425-434
Authors:
MURPHY EL
BRYZMAN S
GLYNN S
AMETI D
THOMSON R
WILLIAMS A
NASS C
OWNBY H
SCHREIBER G
NEMO G
NEAL K
Citation: El. Murphy et al., RISK-FACTORS FOR HEPATITIS-C VIRUS (HCV) INFECTION IN US BLOOD-DONORS- LACK OF ASSOCIATION WITH DRUG INHALATION, Transfusion, 38(10), 1998, pp. 269-269
Authors:
PLANCOULAINE S
BUIGUES RP
MURPHY EL
VANBEVEREN M
POULIQUEN JF
JOUBERT M
REMY F
TUPPIN P
TORTEVOYE P
DETHE G
MOREAU JP
GESSAIN A
Citation: S. Plancoulaine et al., DEMOGRAPHIC AND FAMILIAL CHARACTERISTICS OF HTLV-I INFECTION AMONG ANISOLATED, HIGHLY ENDEMIC POPULATION OF AFRICAN ORIGIN IN FRENCH-GUIANA, International journal of cancer, 76(3), 1998, pp. 331-336
Authors:
MODAHL LE
YOUNG KC
VARNEY KF
KHAYAMBASHI H
MURPHY EL
Citation: Le. Modahl et al., ARE HTLV-II-SEROPOSITIVE INJECTION-DRUG USERS AT INCREASED RISK OF BACTERIAL PNEUMONIA, ABSCESS, AND LYMPHADENOPATHY, Journal of acquired immune deficiency syndromes and human retrovirology, 16(3), 1997, pp. 169-175
Authors:
SCHREIBER GB
MURPHY EL
HORTON JA
WRIGHT DJ
GARFEIN R
CHIEN HC
NASS CC
Citation: Gb. Schreiber et al., RISK-FACTORS FOR HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I AND TYPE-II (HTLV-I AND HTLV-II) IN BLOOD-DONORS - THE RETROVIRUS EPIDEMIOLOGY DONOR STUDY, Journal of acquired immune deficiency syndromes and human retrovirology, 14(3), 1997, pp. 263-271
Authors:
MURPHY EL
GLYNN S
FRIDEY J
SMITH J
SACHER R
NASS C
OWNBY H
KONG F
NEMO G
Citation: El. Murphy et al., INCREASED INCIDENCE OF BACTERIAL-INFECTIONS DURING PROSPECTIVE FOLLOW-UP OF HTLV-II AND HTLV-I SUBJECTS, Transfusion, 37(9), 1997, pp. 292-292
Authors:
MURPHY EL
FRIDEY J
SMITH JW
ENGSTROM J
SACHER RA
MILLER K
GIBBLE J
STEVENS J
THOMSON R
HANSMA D
KAPLAN J
KHABBAZ R
NEMO G
WILLIAMS AE
NASS C
JACKSON CM
OWNBY H
KLEINMAN S
HUTCHING S
BUSCH MP
EVANS C
GILCHER RO
SCHREIBER GB
SACHER R
LUBAN N
HOLLINGSWORTH CG
NEMO GJ
Citation: El. Murphy et al., HTLV-ASSOCIATED MYELOPATHY IN A COHORT OF HTLV-I AND HTLV-II-INFECTEDBLOOD-DONORS, Neurology, 48(2), 1997, pp. 315-320
Authors:
MURPHY EL
GLYNN SA
FRIDEY J
SACHER RA
SMITH JW
WRIGHT DJ
NEWMAN B
GIBBLE JW
AMETI DI
NASS CC
SCHREIBER GB
NEMO GJ
Citation: El. Murphy et al., INCREASED PREVALENCE OF INFECTIOUS-DISEASES AND OTHER ADVERSE OUTCOMES IN HUMAN T-LYMPHOTROPIC VIRUS TYPE-I-INFECTED AND TYPE-II-INFECTED BLOOD-DONORS, The Journal of infectious diseases, 176(6), 1997, pp. 1468-1475
Citation: El. Murphy, THE CLINICAL EPIDEMIOLOGY OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-II (HTLV-II), Journal of acquired immune deficiency syndromes and human retrovirology, 13, 1996, pp. 215-219
Authors:
KAPLAN JE
KHABBAZ RF
MURPHY EL
HERMANSEN S
ROBERTS C
LAL R
HENEINE W
WRIGHT D
MATIJAS L
THOMSON R
RUDOLPH D
SWITZER WM
KLEINMAN S
BUSCH M
SCHREIBER GB
WILLIAMS AE
NASS CC
OWNBY HE
SHAFER AW
KLEINMAN SH
HUTCHING S
BUSCH MP
GILCHER RO
SMITH JW
THOMSON RA
NEMO GJ
ZUCK TF
Citation: Je. Kaplan et al., MALE-TO-FEMALE TRANSMISSION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-IAND TYPE-II - ASSOCIATION WITH VIRAL LOAD, Journal of acquired immune deficiency syndromes and human retrovirology, 12(2), 1996, pp. 193-201
Authors:
MURPHY EL
WILKS R
HANCHARD B
CRANSTON B
FIGUEROA JP
GIBBS WN
MURPHY JYN
BLATTNER WA
Citation: El. Murphy et al., A CASE-CONTROL STUDY OF RISK-FACTORS FOR SEROPOSITIVITY TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I (HTLV-I) IN JAMAICA, International journal of epidemiology, 25(5), 1996, pp. 1083-1089
Authors:
MURPHY EL
WILKS R
MORGAN OS
HANCHARD B
CRANSTON B
FIGUEROA JP
GIBBS WN
MURPHY JYN
BLATTNER WA
Citation: El. Murphy et al., HEALTH-EFFECTS OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I (HTLV-I) IN A JAMAICAN COHORT, International journal of epidemiology, 25(5), 1996, pp. 1090-1097
Authors:
MURPHY EL
BRYZMAN S
WILLIAMS AE
COCHIEN H
SCHREIBER GB
OWNBY HE
GILCHER RO
KLEINMAN SH
MATIJAS L
THOMSON RA
NEMO GJ
Citation: El. Murphy et al., DEMOGRAPHIC DETERMINANTS OF HEPATITIS-C VIRUS SEROPREVALENCE AMONG BLOOD-DONORS, JAMA, the journal of the American Medical Association, 275(13), 1996, pp. 995-1000
Authors:
AGRANOFF D
VARNEY K
KHAYAMBASHI H
MURPHY EL
Citation: D. Agranoff et al., HUMAN T-LYMPHOTROPIC VIRUS TYPE-II SEROPREVALENCE AMONG EMERGENCY DEPARTMENT AND CLINIC PATIENTS, Western journal of medicine, 164(6), 1996, pp. 481-485
Authors:
MURPHY EL
GLYNN S
FRIDEY J
SACHER R
SMITH J
NEWMAN B
GIBBLE JW
HANSMA D
SCHREIBER G
NEMO G
Citation: El. Murphy et al., MEDICAL CONDITIONS ASSOCIATED WITH HUMAN T-LYMPHOTROPIC VIRUS TYPE-I AND TYPE-II (HTLV-I AND HTLV-II) INFECTION, Transfusion, 36(9), 1996, pp. 171-171
Authors:
MURPHY EL
SHAH M
BUTCHER AC
MALOBISKY K
STRAMER S
CHEN W
WEIBLEN B
Citation: El. Murphy et al., COMPARISON OF HTLV-I II PCR SCREENING WITH SEROLOGIC ASSAYS IN AN HTLV-II ENRICHED POPULATION/, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 159-159
Authors:
KAPLAN JE
KHABBAZ RF
MURPHY EL
HERMANSEN S
ROBERTS C
Citation: Je. Kaplan et al., VIRAL LOAD IS ASSOCIATED WITH MALE-TO-FEMALE SEXUAL TRANSMISSION OF HTLV-I AND HTLV-II, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 178-178
Authors:
MODAHL LE
YOUNG K
VARNEY K
KHAYAMBASHI H
MURPHY EL
Citation: Le. Modahl et al., INJECTION-DRUG USERS (IDU) SEROPOSITIVE FOR HTLV-II ARE AT INCREASED RISK FOR PNEUMONIA, ABSCESS AND LYMPHADENOPATHY, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 188-188
Authors:
MURPHY EL
WATANABE KK
SCHREIBER GB
SACHER RA
Citation: El. Murphy et al., DIFFERENCES IN CLINICAL LABORATORY PARAMETERS ASSOCIATED WITH HTLV-I AND HTLV-II INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 209-209